Please note that the list of Invited Speakers is subject to change, and will be updated continuously..
Sang Hoon Ahn
Prof Ahn is a Professor of Yonsei University College of Medicine and a Director of Planning and Management Headquarter, Severance Hospital, Yonsei University Health System. His major research interests include chronic hepatitis B, C, cirrhosis and liver cancer. Among these, he has more interests in molecular biology of viral hepatitis and clinical trials for new drug development.
Head of Hepato-Gastroenterology Department, Hospital Saint Jospeh, Associate Professor, Paris Hospital Medical College. Dr Bourlière and his group have participated in hepatitis B and C and HCC clinical trials; His research focus were the use and development of non invasive biomarkers in hepatitis and is more currently development of new antiviral therapy for hepatitis C, B.
Chan Wah Kheong
Associate Professor and Consultant Gastroenterologist, Department of Medicine, University of Malaya, University of Malaya Medical Centre and University of Malaya Specialist Centre. His area of expertise and research interests include Diagnostic and therapeutic gastrointestinal endoscopy, viral hepatitis B and C, hepatocellular carcinoma, and non-alcoholic fatty liver disease.
Associate Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong. His main interest of research is clinical studies on GI and liver cancers. Dr. Chan is also severing in the editorial board of Liver international and the associate editor of the Asia-Pacific journal of Clinical Oncology
Y. K. Chawla
Prof Chawla is an Executive Director of Post Graduate Institute of Medical Education and Research (PGIMER), a Head of Department of Hepatology in PGIMER. His main research work has been in the areas of cirrhotic and noncirrhotic portal hypertension, Budd-Chiari syndrome, viral hepatitis and biliary diseases.
Chee Cheng Ean
Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS) and Assistant Professor of Medicine, Yong Loo Lin School of Medicine, National University of Singapore (NUS). Her clinical research portfolio includes a novel biomarker study in colorectal cancer which was awarded institutional and national grant funding.
Prof. Chen is a Professor at the Hepatitis Research Center, National Taiwan University Hospital. His areas of expertise and research interests include Molecular Biology of Hepatitis Viruses, Liver carcinogenesis, prevention and treatment of chronic viral hepatitis.
Prof Chow is a Senior Consultant at Division of Surgical Oncology, National Cancer Centre Singapore, Senior Consultant Surgeon, HPB/transplant, Singapore General Hospital. His area of expertise are hepatic, biliary and pancreatic surgery; minimally invasive surgery including single-incision prt surgery; surgical oncology; gastro-intestinal stromal tumours, neuroendocrine tumours.
Dan Yock Young
Chair of the University Medicine Cluster National University Health System; Head, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore
Senior Consultant of the Division of Gastroenterology and Hepatology, National University Hospital; Adjunct at the Cancer Science Institute National University Singapore.
Peter R. Galle
Professor, Department of Internal Medicine, University Medical Center. His research has focused on elucidating important aspects of apoptotic cell death in the liver and immune escape of tumour cells. He was awarded several prizes, amongst others the prestigious Tannhauser award, the highest prize of the German Society for Digestive Diseases
Professor of Medicine at the University of Auckland, New Zealand; Chief Hepatologist, Transplant Physician and Deputy Director of the New Zealand Liver Transplant Unit at Auckland City Hospital
Hepatobiliary Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia; Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; His research grants include Risbin - Iptekdok - BPPT, Jakarta, 1998; Miyakawa Research Foundation, Tokyo, 2000; National Strategic Research Grant - Ministry of Education, Director of Higher Education Grant, Jakarta, 2009; Operational Research Grant – Dr. Cipto Mangunkusumo Hospital, Jakarta, 2015.
Professor Consultant of the Department of Medicine, Division of Gastroenterology and Hepatology at the Stanford University; Senior Medical Director at St. Joseph’s Medical Center in Phoenix, Arizona; Clinical Professor of Medicine (Adjunct), University of Nevada (Las Vegas); Medical Director Hepatitis B Foundation Doylestown, PA.
Consultant of Department of Gastroenterology & Hepatology, Singapore General Hospital, Adjunct Assistant Professor at Duke-NUS Graduate Medical School, Clinical Lecturer, Yong Loo Lin School of Medicine, National University of Singapore and Chairperson, Executive committee, National Foundation of Digestive Diseases, Singapore 2016.
Professor at Internal Medicine at Yonsei University College of Medicine. His area of expertise and research interests are liver cancer, hepatitis virus and chronic liver diseases related with viral hepatitis especially B and C virus, and hepatocellular carcinoma.
Dr Jonathan Lee is an Assistant Professor, National University of Singapore, Associate Consultant, National University Hospital. His ongoing research activities include Reduction in steatohepatitis through bacterial bile acid modification in the gut and Reduction in steatohepatitis through bacterial bile acid modification in the gut.
Khin Maung Win
Prof. Khin Maung Win is an Honorary Professor at the University of Medicine (1), Ministry of Health in Yangon. His research interests include Viral Hepatitis (B) & (C) and HCC; Founder and Patron of Myanmar Gastroenterology and Liver Society.
Senior Consultant, Division of Surgical Oncology (Hepatobiliary & Pancreatic Surgery), National University Cancer Institute, Singapore (NCIS). Dr Kow has keen interest in research activities involving development of surgical techniques in HPB surgery and outcome of surgical treatment for HPB malignancies. The other areas that he is keen to research on are liver transplantation, peri-transplant management and outcome studies.
Associate Professor in the Gastroenterology, Director of the Gastroenterology and Hepatology Division, Head of the “A. M. e A. Migliavacca” Center for Liver Disease at the Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, University of Milan, Milan. He has spoken internationally about liver disease, specifically the natural history of HBV and antiviral treatment,and currently involved in national and international HBV clinical trials.
Professor Lesmana is currently the Chairman of Digestive Disease and GI Onkology Centre , Medistra Hospital, a Professor in Internal Medicine, Consultant Gastroentero-Hepatologist , Department of Medicine, University of Indonesia
Professor Levrero is Professor of Medicine at the Sapienza University in Rome, Italy. He has recently joined the Centre de Recherche en Cancérologie de Lyon (CRCL) in Lyon, France, where he leads a Research Unit on ”Epigenetics and Epigenomics of Hepatocellular Carcinoma”, and the Service d’Hepatologie et Gastroenterologie - Hopital de la Croix Rousse - Hospices Civils de Lyon, France, where he continues his academic practice in hepatology. He serves as Associate Member and Director of the Functional Genomics platform at the IIT-Sapienza Center for Life NanoScience (CLNS) in Rome
Prof Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital; Professor of Medicine, The University of Melbourne; consultant infectious diseases physician, Alfred Hospital and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. Her research focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. She is passionate about research translation, science communication and the role of community in research and health.
Prof Liu a Professor at the Department of Internal Medicine and Graduate Institute of Clinical Medicine at the National Taiwan University College of Medicine, and a visiting staff member at Hepatitis Research Center at the National Taiwan University Hospital
Lim Seng Gee
Prof Lim is Director of Hepatology, Dept of Gastroenterology & Hepatology National University Hospital, Chairman of the Singapore Hepatitis Conference, Governing Council Member, International Association for Study of Liver; and Adjunct Principal Investigator, Institute of Molecular and Cell Biology, ASTAR
Prof Locarnini is a Head of Department at Research & Molecular Development, Victorian Infectious Diseases Reference Laboratory, University of Melbourne, WHO Regional Reference Laboratory for Hepatitis B. His research interests include Hepatitis A, B, C, D, E, public health, co-infection with HIV, pathogenesis, cure strategies.
Professor of hepatology, University of Paris, Head of the Viral Hepatitis Research Unit, Hôpital Beaujon, Clichy. His major focus has been on viral hepatitis therapy, and as such he has been the principal investigator on initial trials of first interferons and antivirals and on several pivotal studies investigating therapies for chronic hepatitis B and C.
Associate Professor of Medicine, Prince of Songkla University, Hat Yai; Director of NKC Institute of Gastroenterology and Hepatology Songklanagarind Hospital, Hat Yai; Steering Committee of the Asia-Pacific Association for the Study of the Liver (APASL); Council member of the International Coalition of Hepatology Education Providers (IC-HEP) in Asia Pacific.
Professor of hepatology at the Université Pierre et Marie Curie and the Hôpital Pitié-Salpêtrière Medical School. His main research interests are in the field of nonalcoholic fatty liver disease (NAFLD); the mechanisms, risk factors, and progression of liver fibrosis in viral and metabolic diseases; and the treatment of viral hepatitis and hepatocellular carcinoma.
Ruimy Family President’s Distinguished Professor of Medicine and Professor of Medicine in Surgery in the Division of Gastroenterology/Hepatology at the University of Pennsylvania in Philadelphia, Pennsylvania. He is the Director of Hepatology, Medical Director of Liver Transplantation, and the Director of the Viral Hepatitis Center.
Tan Chee Kiat
Senior Consultant at the Department of Gastroenterology and Hepatology of Singapore General Hospital; Deputy Director (Solid Organ Transplant) of the SingHealth Transplant; Adjunct Associate Professor at the Duke-NUS Graduate Medical School; Clinical Associate Professor, Yong Loo Lin School of Medicine, National University of Singapore.
Tan Soek Siam
Dr. Tan Seok Siam is a Consultant Hepatologist and Head of the Selayang Hospital in Malaysia. Her research interests include viral hepatitis, liver failure and autoimmune liver disease.
Professor-Director of the Department of Gastroenterology at St Vincent’s Hospital and the University of Melbourne, Australia and an Adjunct Assistant Professor of the Department of Gastroenterology, Duke University Medical Center. His research focusses on improving outcomes for people living with viral hepatitis. He was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV, and is an active clinical investigator for trials evaluating the efficacy of novel antiviral DAA regimens
Prof Thimme is the Director of the Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases). His research focus lies on the immune responses in hepatitis B virus (HBV) and hepatitis C virus (HCV) infection as well as hepatocellular carcinoma (HCC). His main focuses are the immunological determinants of viral clearance and persistence with a special focus on CD8+ T cells.
Professor Revill is a Senior Medical Scientist at the Victorian Infectious Diseases Reference Laboratory (VIDRL), Section Head of the Molecular Virology Group, Division of Research and Molecular Development and the President of Australasian Centre for Hepatitis Virology.
Senior Social Development Specialist, Sustainable Development and Climate Change Department, Asian Development Bank. Dr Roth co-led the preparation of ADB’s new Operational Plan for Health 2015–2020, which aims to double ADB’s health sector operations by 2020. She focuses on increasing ADB private sector health investments, strengthening digital health infrastructure in Asia and the Pacific, advancing health impact assessment and resource mobilization for infectious diseases and health security related investments.
Shah Samir Ramnik
Dr Samir Ranik is a Head of the Department of Hepatologist at the Institute of Liver Diseases, HPB Surgery and Transplant at the Global hospital, Mumbai; Council Member of International Liaison Committee, Asian Pacific Association for the Study of the Liver (APASL).
Professor of internal medicine, and the head of G.I & liver unit, Mansoura University. He is the founder and head of the Association of Liver Patients Care (ALPC) & the Egyptian Liver Research Institute And Hospital ( ELRIAH )
Prof. Kumar Visvanathan is a senior ID Physician and Clinical Director of Medicine and Emergency Services at St Vincent's Hospital, Melbourne, Professor of Medicine at the University of Melbourne (St. Vincent's Hospital, Melbourne). He was the first person to demonstrate the importance of Innate Immunity in HBV.
Yang Wei Lyn
Dr. Yang is the Head of Department and Senior Consultant of the Endoscopy Centre, Gastroenterology & Hepatology at Tan Tock Seng Hospital. Her clinical interests include General Gastroenterology and Clinical Hepatology.
Prof Yuen is a Chair Professor and Endowed Professor in Medicine of the Li Shu Fan Medical Foundation, the Chief of the Division of Gastroenterology and Hepatology, the Deputy Head of University Department of Medicine, The University of Hong Kong, the Deputy Chief of Service of the Department of Medicine, Queen Mary Hospital, Hong Kong and the Assistant Dean of the Faculty of Medicine, the University of Hong Kong.